Chitogel Revenue and Competitors
Estimated Revenue & Valuation
- Chitogel's estimated annual revenue is currently $2.5M per year.
- Chitogel's estimated revenue per employee is $251,000
Employee Data
- Chitogel has 10 Employees.
- Chitogel grew their employee count by -17% last year.
Chitogel's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Field Sales- United States | Reveal Email/Phone |
2 | Business Support | Reveal Email/Phone |
3 | National Account Manager | Reveal Email/Phone |
Chitogel Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Chitogel?
Chitogel is a postoperative hydrogel nasal dressing that can be applied to sinuses after endoscopic sinus surgery. The hydrogel is made by combining chitosan succinamide, dextran aldehyde, and, a sodium phosphate buffer solution. Many patients with chronic sinusitis whose conditions fail to respond to medical treatment require surgery to return their sinus cavities to normal. Chitogel is designed to improve surgical outcomes in the treatment of sinusitis. Chitogel addresses a number of the traditional sinus surgery shortcomings: • Separate tissue or structures compromised by surgical trauma • Prevent adhesions between mucosal surfaces in the nasal cavity • Minimise ostial stenosis • Control minimal bleeding by tamponade effect, blood absorption, and platelet aggregation • Enhance wound healing and the patient experience
keywords:N/AN/A
Total Funding
10
Number of Employees
$2.5M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $25.7M | 146 | 9% | N/A |